{"name":"BridGene Biosciences Inc.","slug":"bridgene-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxPRWg0UGJIejdLLWRwdzdON0NOUGs0bVpKR0E3ZU0xa0pCTk9kcDFOZkNXTHZ5Z1hMNEhLd25MVGduYzc1Sm5jRFlkdEJXSFJwbkdiTVJYLVRRZVY5SjdlVks3V25za1poT2tKMWlOX0NWcUloNk1LeGplUm9TQ3RCVHZYS3daZ19LUXI1VDkyUjZNYWRYRnBuek12UU5MTDNiOTBueVVFYnAtS2ViM1kySFRDT0FKM0oxTUtta3Y2dVNEc3FLclNNR3F4TDQ2Mkd1bzVWUk1FcFNQeFNhTHJzd0dUQndXekxEU0lqQ0p6bWFKSjlfVlZqLWNjY2NNY3V6RE5VcjNPVGVYQjFoTVRaaTBUOA?oc=5","date":"2026-01-27","type":"pipeline","source":"PR Newswire","summary":"/C O R R E C T I O N -- BridGene Biosciences/ - PR Newswire","headline":"/C O R R E C T I O N -- BridGene Biosciences/","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOdktyUDBqWmtMaXhjRS00U1gtRXdwa0QycG9mcFJZX0pCRFQyTjBNXzFRdXlwZFZiVnU3R1Fyc1dDV2ZacFpqWEdvaGRjOHNTSzBTZ1FLWm1HajcxRlhFd253TmV0V08yMlhFMjEzYW9MMWNZOEpxMTVjMUpNSHJaWlF3blNmcnhHWlFmcS1abDJXVThTWm1pRndaZlg0enpzWXB0Q191cFZqYW9LcWp2cU1kalJCSnZSTjh4WFQtRjRkbzNCc2lUQVVFS21TaWw0Y1QyMXR0TGpMVnUzUERjQnJ3?oc=5","date":"2026-01-05","type":"pipeline","source":"PR Newswire","summary":"BridGene Biosciences Appoints Nobel Laureate Bruce A. Beutler, M.D., to Scientific Advisory Board - PR Newswire","headline":"BridGene Biosciences Appoints Nobel Laureate Bruce A. Beutler, M.D., to Scientific Advisory Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPQjJ2VUhMM1Q5LUpUZWtQbERDaUNmenM4b3htblk1Slk2eHdpRjVoNk5iWHZzZ2NBWkNlUi1SUFZacERUaHBRemU5cFdGSUk5b3JaeTFsYnM4VUxrd0ZoVFRpUEw1bE5VcjU5ZG9FUjc3dkNSZHNxTzNFR2VSR0xfQmNsbw?oc=5","date":"2025-10-07","type":"pipeline","source":"BioWorld News","summary":"Takeda ditches cell therapy business - BioWorld News","headline":"Takeda ditches cell therapy business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQ1IwNGhyMVVSYzNnN3ZnRW1XbFVHdUxnWWNGWXJoa19rRWtmVU9Ya1JoTmRxUGZILS1wREFFdGxoT0tHNlZJSDRlNnViMHpZVVVxMlFmbFM1OXBvcVJXeUs5NnB6bVVZb2lvZGtOV1VySDJWYzR2eEZaU212bkNyWGVsTl8xMmJZYjYyOEJHZ25xMXl4QWdqQ1RJa19GX09nM2lTaHJZSXBxQmYzV05MMWxKeWZBbVJH?oc=5","date":"2025-06-19","type":"pipeline","source":"C&EN","summary":"Executives, investors stick to basics at BIO 2025 - C&EN","headline":"Executives, investors stick to basics at BIO 2025 - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOY3EtdWdTVjc5RXRBS0w1dDQ5eVlTVi1IZzNrWGpRblh4VW1mbVN0M0ZvMjg4VjNncURBYnFsY1FMVzdLTEttUkxsODBPckdQdWVWQy1xUTI4eGFTeHY3OXhCNUxmN3RlMjNoZWVldVNaLUVleFJwTUg1Y0JjVUlBVnp5a3BCY1dGNHluMFVB?oc=5","date":"2025-03-13","type":"deal","source":"Pharma Voice","summary":"Takeda’s $770M deal deepens Big Pharma’s omics push - Pharma Voice","headline":"Takeda’s $770M deal deepens Big Pharma’s omics push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQcDlmVEYxQUpFVU5mVzNmaG9Vb0FpdHMtZzQybW9KWVQ2RE1mMXRETEZ5M05sdWVMUEZneklUVGNwNWFPa3VkNjUwOUJGNkJNYVhkcXdKRkE2VGxXa3UzaUwwNmc4RGsybmxQc0R4MThSNWRWVDJSa1NXRzFpZTREUnZsYk1BbGlJNjRncEpqQ3Vramh0MGdKNDRCd2ExOFYxblFrRkNfSUNvQ0J6ZFVkNEh1QU5lNGdmX0pB?oc=5","date":"2025-02-28","type":"pipeline","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Eisai's US restructuring; China investigates former NMPA official; Pfizer-Summit collab - Fierce Pharma","headline":"Fierce Pharma Asia—Eisai's US restructuring; China investigates former NMPA official; Pfizer-Summit collab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQU2NlRl9WUzd0aV8xd3laWUZKVlphWDBYWjQtWVdYM0dRSmVyVG1nNi05QmRfX05fYWNNc2pvNm9Kb1dLRENIQVU3NkI3SlBCUnhlVFpaVHRuUnVFUjlNdlFQcDZWM3Q1eUtJaUxGU1lOVk1TaDhLUEFVSF90TzhudUlhZGtTSE8tRXZmM3haMEVQbFgzWXUwcW1LTFRHU3pfcTdJbVBQWlhOaHV4QXlsSkFLSW4?oc=5","date":"2025-02-25","type":"deal","source":"Contract Pharma","summary":"BridGene Biosciences, Takeda Partner to Discover Small Molecule Drugs - Contract Pharma","headline":"BridGene Biosciences, Takeda Partner to Discover Small Molecule Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxPZWxleEk0Q3NiQnhoM2F6LWdxVXJCU3h5UGR2MnlPVDU4YzN1c1pmNkU0ZURDZVh5dHBHV1FON3B5a01FdXdtOEZCcGNGbkdtbW9HM2gyU01wMEkyRGlURWZQSlhIdmFtYTJLT2dFMzVhNmdSdVlubVEtUU9kVF9YOUpQZ1Bzc1RjWHRtNjQ4OFBhOFpuS0NxTEU2aE83RkkzVVlwVE5Tajc2ZldjT3NCR09Gai0xdGVfbXNzM3ZWQS1JU3R3eEl5UFNrTk5Md01VZXFIaDdFcmt3ZDB5N1dpMVFGVkN0UElHR3Z2QVJxN19pOWpDWTNjSlZ1YndKVFNtTjctUXFNaVV6S0Utakg0UUdtT3M?oc=5","date":"2024-08-01","type":"deal","source":"PR Newswire","summary":"BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision Oncology - PR Newswire","headline":"BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precisio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPTnlHZ0xYeFJpOUNPdXF6SW9Mci03eEFjaTdfelpDY3c1Vm9pekxLYU81azdtU2NNTWQtUVR3WDBEV3RSOHR3WndwVHNmeWtFUVo3TUlZdkFkM2FzNzNXa2dNclRQNk1OLXFOcHE3dGV1cWhKZUh4YmYxTmF3NnI5cTlfSTdMS21NNGoxdUZQSW9IZGtwTFBkdWlQYjBzT1FhZFExLXlicmFCbUVCVkU4c1hCQzRhb3RTUTltSjV0ekx6c2lGbnVmZDVuVF9aeHBzNnd3X1MxUUR5c0t2dWFXdjlGVG1CSVFaS3NnZm5vV3NBcnNPb2hrUXA0ejFKTl8waEJ2NWs3NUt0MGEyR0ZuMHlwTS1pVS1VRUowbThLUFZ0c2xrSmhwNzdCRk5aVW1RcGIzOFBMTmdWeWh6?oc=5","date":"2022-07-27","type":"pipeline","source":"PR Newswire","summary":"BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs - PR Newswire","headline":"BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics P","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}